BioXcel Therapeutics (BTAI) Work In Process (2022 - 2025)

BioXcel Therapeutics' Work In Process history runs 4 years deep, the most recent figure standing at $368000.0 for Q4 2025.

• In Q4 2025, Work In Process changed N/A year-over-year to $368000.0; the TTM figure through Dec 2025 stood at $368000.0 (changed N/A YoY), while the FY2025 annual figure was $368000.0, changed N/A from the prior year.
• Work In Process was $368000.0 for Q4 2025 at BioXcel Therapeutics, down from $387000.0 in the prior quarter.
• In the past five years, Work In Process ranged from a high of $708000.0 in Q4 2022 to a low of $122000.0 in Q3 2022.
• Historically, Work In Process has averaged $437125.0 across 4 years, with a median of $395000.0 in 2022.
• Biggest YoY gain for Work In Process was 395.9% in 2023; the steepest drop was 8.05% in 2023.
• A 4-year view of Work In Process shows it stood at $708000.0 in 2022, then slipped by 8.05% to $651000.0 in 2023, then slumped by 40.55% to $387000.0 in 2024, then decreased by 4.91% to $368000.0 in 2025.
• The last three Work In Process figures came in at $368000.0 (Q4 2025), $387000.0 (Q2 2024), and $253000.0 (Q1 2024), per Business Quant data.